Lin Daniel W, Herr Harry W, Dalbagni Guido
Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
J Urol. 2003 Mar;169(3):961-3. doi: 10.1097/01.ju.0000051907.16079.63.
We determined the outcome in patients who underwent urethrectomy after cystectomy followed by routine urethral wash cytology versus those not followed by urethral wash cytology who presented with bleeding or urethral discharge. We retrospectively evaluated the outcome in post-cystectomy urethrectomy cases at our institution from 1994 to 2000.
A total of 24 patients with a median age of 70.5 years underwent urethrectomy after cystectomy, including 17 due to asymptomatic, positive urethral wash cytology (group 1) and 7 who were not followed by urethral wash and presented with bleeding/urethral discharge (group 2). Median time from cystectomy to urethrectomy was 11.4 months (range 6.7 to 67.1). Median followup after cystectomy and urethrectomy was 37 and 27.7 months, respectively.
Urethrectomy pathological evaluation showed pTis disease in cases 12 (50%), pT0 in 9 (37.5%) and pT1 in 3 (12.5%). Cystectomy pathology was organ confined (pT0, pTis and pT1-pT2b disease) in 12 cases (50%), nonorgan confined (pT3a-pT4) in 6 (25%) and pT any N1 in 5 (21%). Cystectomy pathology was unknown in 1 case. At the most recent followup there was no evidence of disease in 14 patients (58%), 5 (21%) were alive with disease, 3 (12.5%) were dead of disease, 1 (4%) was dead of other causes and disease status was unknown in 1 (4%). There was no statistical difference in survival in groups 1 and 2 when controlling for original bladder tumor stage. Cox regression analysis revealed that cystectomy pathology was the only statistically significant parameter of disease-free survival (p = 0.011), while urethrectomy pathology and followup method (urethral washing versus no washing) were not significant. There were no perioperative or postoperative complications and no patients died.
There was no significant survival difference in patients followed and not followed with urethral washing. Longer followup and increased patient numbers are needed to determine the significance of these findings.
我们比较了膀胱切除术后接受尿道切除术并常规进行尿道冲洗细胞学检查的患者与未进行尿道冲洗细胞学检查但出现出血或尿道分泌物的患者的预后情况。我们回顾性评估了1994年至2000年在我们机构进行膀胱切除术后尿道切除术病例的预后。
共有24例患者,中位年龄70.5岁,在膀胱切除术后接受了尿道切除术,其中17例因无症状但尿道冲洗细胞学检查呈阳性(第1组),7例未进行尿道冲洗且出现出血/尿道分泌物(第2组)。从膀胱切除术到尿道切除术的中位时间为11.4个月(范围6.7至67.1个月)。膀胱切除术和尿道切除术后的中位随访时间分别为37个月和27.7个月。
尿道切除术病理评估显示12例(50%)为pTis疾病,9例(37.5%)为pT0,3例(12.5%)为pT1。膀胱切除术病理显示12例(50%)为器官局限性病变(pT0、pTis和pT1 - pT2b疾病),6例(25%)为非器官局限性病变(pT3a - pT4),5例(21%)为任何pT分期的N1病变。1例患者的膀胱切除术病理情况未知。在最近的随访中,14例患者(58%)无疾病证据,5例(21%)带瘤生存,3例(12.5%)死于疾病,1例(4%)死于其他原因,1例(4%)疾病状态未知。在控制原膀胱肿瘤分期后,第1组和第2组的生存率无统计学差异。Cox回归分析显示,膀胱切除术病理是无病生存的唯一具有统计学意义的参数(p = 0.011),而尿道切除术病理和随访方法(尿道冲洗与未冲洗)无统计学意义。无围手术期或术后并发症,无患者死亡。
进行尿道冲洗和未进行尿道冲洗的患者在生存率上无显著差异。需要更长时间的随访和更多的患者数量来确定这些发现的意义。